Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications
about
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.Temporal and demographic patterns of non-Hodgkin's lymphoma incidence in Pennsylvania.Automatic lymphoma classification with sentence subgraph mining from pathology reports.Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.Rapidly increasing incidence of ocular non-hodgkin lymphoma.A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaSurvival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte developmentLymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturationNo survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis.Exposure to non-arsenic pesticides is associated with lymphoma among farmers in SpainAlcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada.Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality TrendsComparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseEffectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.Risk of lymphoma subtypes after solid organ transplantation in the United States.Development of query strategies to identify a histologic lymphoma subtype in a large linked database system.Improvements in survival after follicular lymphoma by race/ethnicity and socioeconomic status: a population-based studyExposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysisEvaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry.Use of non-steroidal anti-inflammatory drugs and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis.Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA.Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.Hematologic malignancies: an opportunity to fill a gap in cancer surveillance.Decreasing mortality from non-Hodgkin lymphoma in Australia.Cancer survival in California Hispanic farmworkers, 1988-2001.Cancer incidence in Canada: trends and projections (1983–2032).Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.The Time of the Insult/Triggering Event in Primary Osteosarcoma and Ewing’s Sarcoma of Bone as Determined by Incubation Period Modeling and Age Distribution of Such Malignancies
P2860
Q28271344-A7BE82FC-42BA-42DF-AAFF-BD0D0A4C77BBQ30479763-EBC66D4C-C920-4057-92B4-912917B1990CQ33585882-2B4C5F1E-E911-4D97-B2D2-08F8075D7FFFQ33718809-D2957AE8-1222-4D3A-9F8E-94DF3C1D58B3Q33956734-38F915F2-5828-4807-BCC1-EF700AF3E3B9Q34101867-038A658D-4B02-42C5-BF26-96D657B77417Q34158874-AF026C07-1221-4238-AF92-8DCAC4E76D49Q34544397-88D57D20-7B6C-4CC0-93A7-DC89DAC741F5Q34723932-9160B9C3-76B4-4871-9BDB-28E821C5FF71Q34890475-B8CF6B66-8321-4F4F-AF3C-1FCA50EB403DQ34972303-64BD6DCE-9D47-4D28-9A02-840A203CACD2Q35036813-3AA5316C-F589-4327-872F-04E922EA4781Q35126129-2BF2DA5E-D361-4816-93E0-54329BD8FA3AQ35164271-44D63D7E-83BA-4263-9D78-EEA94874F861Q35197308-E28BD111-A982-4A9D-B3BC-2273825F3F3DQ36144102-E7EC367E-2DC4-4268-BF54-BC553A24114EQ36184245-EF18A62F-4BB7-48F0-A48E-41391B24D0D8Q36191920-A7107586-643E-4067-BA8E-920FB555FEFCQ36429463-965FEAD8-4306-4BFC-908B-A1140694DFE6Q36463900-DDBCAF93-56D7-4281-B81B-273C25AB3245Q36777008-F3FB3103-F584-4FF0-85B4-F801647EC67DQ36910325-CB650F2F-871C-40AA-9489-BE296DAD2658Q37003308-7C62003E-0FC8-4B8B-A5AB-4C6C20F80056Q37175927-4D5024E2-3C94-49D8-866D-15E1F186FDBBQ37242294-2DE984AE-2A2D-4EB7-A212-778BAA3916CEQ37311256-07B82E06-333B-43DB-A0BC-88D603B55454Q38124058-A39B6663-60CF-4384-89B7-0AD5445C5F8EQ38262832-F4CF50FF-5AAD-456A-9D66-5012D87A90AAQ39372883-0EF9BC9F-F3D7-4B3A-9191-32B48A54B657Q40163048-18825191-E8B6-405D-A8E3-A653EBB14D16Q40239082-73D13A02-6091-41DD-BEB6-09F369DAFC8CQ43423234-AA9338EF-B414-4FC4-81A3-BD0CE26AECCBQ43676080-B1B6FED7-5FCC-4889-9C4C-1413FE174876Q44010170-E539E462-070C-4B38-87B1-42A4E44E4F0CQ44534626-EAA19E55-C16C-4F74-ACC4-2991ED09B97DQ46495297-67EC98A0-9D74-4360-B210-D84FD92D21BDQ51272700-F6A64E83-F403-4CF2-B50B-F30D07924BF1Q51584616-4D72FC2E-F35F-44E9-BE04-B29C6D215D89Q59106276-1A75EF9D-7334-42C4-91B0-41C684A646D9
P2860
Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@ast
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en-gb
type
label
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@ast
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en-gb
prefLabel
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@ast
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en-gb
P3181
P1476
Expert Review of Non-Hodgkin's ...... is and Subtype Classifications
@en
P2093
C. A. Clarke
P304
P3181
P356
10.1158/1055-9965.EPI-03-0250
P577
2004-01-01T00:00:00Z